Over six months, people using Wegovy (semaglutide) alongside reduced-calorie eating and more activity typically see steady, gradual weight loss — but the headline trial figures reflect longer treatment (72 weeks) at the highest licensed dose, not six months. Individual results vary; not everyone reaches the published averages, and the first six months are often still part of building up to a maintenance dose.
This article explains what the clinical evidence actually shows, why the first six months look the way they do, and how to judge whether Wegovy is working for you. Wegovy is a prescription-only medicine in the UK and is supplied only after a clinical consultation with a GPhC-registered prescriber.
What does the trial data say about Wegovy results?
The only efficacy figure The Weight Clinic can quote for the Wegovy injection comes from the STEP UP clinical trial: adults on the 7.2mg dose lost on average 20.7% of their body weight over 72 weeks, alongside lifestyle support. Individual results vary, and not everyone reaches this.
Two things matter when reading that number. First, it describes 72 weeks of treatment — roughly 16–17 months — not six months. Second, the 7.2mg dose is the higher of the licensed doses; the standard maintenance dose is 2.4mg. The trial average is therefore a long-horizon, high-dose result, not a six-month target.
What weight loss is realistic at 6 months on Wegovy?
At six months, many people are still completing the dose-escalation phase or have only recently reached a maintenance dose, so weight loss is usually a work in progress rather than a final result. Because the published average reflects 72 weeks at 7.2mg, it should not be read as a six-month expectation.
The honest answer is that your six-month figure depends on your starting point, how your body responds, how quickly you titrate, and how closely you combine the medicine with reduced-calorie eating and activity. A prescriber reviews your progress rather than holding you to a trial average. If weight is not moving as hoped, that is information your prescriber uses to adjust the plan — not a sign the medicine has failed.
Why do the first 6 months look slower for some people?
Wegovy is a GLP-1 receptor agonist — it mimics a natural gut hormone that controls appetite, so you feel fuller sooner and for longer and the stomach empties more slowly. To let the body adjust and reduce side effects, the dose is increased gradually rather than started at full strength.
The injection titration runs through six steps: 0.25mg for weeks 1–4, then 0.5mg, 1mg, 1.7mg, 2.4mg, up to a 7.2mg maximum licensed dose. Each step is reviewed by a prescriber, and some people spend longer on a step if side effects need settling. Much of the first six months can therefore be spent building up, which is normal and by design.
The Wegovy injection titration steps
| Step | Dose | Typical timing |
|---|---|---|
| 1 | 0.25mg | Weeks 1–4 |
| 2 | 0.5mg | Next step |
| 3 | 1mg | Next step |
| 4 | 1.7mg | Next step |
| 5 | 2.4mg | Standard maintenance |
| 6 | 7.2mg | Maximum licensed dose |
The exact pace is a prescriber decision based on how you tolerate each step — it is not something to rush.
Who is eligible for Wegovy in the UK?
Wegovy may be an option if you are aged 18 or over and have a BMI of 30 or more (obesity), or a BMI of 27 or more with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
It is not suitable if you are pregnant, planning pregnancy or breastfeeding; have type 1 diabetes; have a personal or family history of medullary thyroid carcinoma or MEN2; have a history of pancreatitis or severe gastrointestinal disease; have an active eating disorder; have severe liver or kidney impairment; or are allergic to the active ingredient. A treatment is prescribed only if clinically appropriate after a free online consultation.
What side effects might affect your 6-month progress?
The most common Wegovy side effects (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. They are usually most noticeable after a dose increase and often ease as your body adjusts, which is one reason titration is gradual.
Serious but rare risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia (particularly alongside certain diabetes medicines), severe gastrointestinal disease and worsening diabetic retinopathy. If side effects are affecting your eating, hydration or quality of life, speak to your prescriber rather than stopping suddenly. You can report suspected side effects through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
How can you get the most from your first 6 months?
- Inject on the same day each week to keep the medicine at a steady level.
- Pair it with lifestyle change — the trial result was achieved alongside reduced-calorie eating and more activity, not the injection alone.
- Expect appetite change, not magic — Wegovy makes eating less feel more manageable; the food choices are still yours.
- Track trends, not single days — weight fluctuates daily; look at the direction over weeks.
- Keep prescriber reviews — they confirm the medicine is working and safe before the next dose step.
How does Wegovy compare with other options at 6 months?
Wegovy is one of several treatments; the right choice is a clinical decision, not a league table. The Weight Clinic also supplies Mounjaro (tirzepatide), the Wegovy Tablet (oral semaglutide), and Foundayo (orforglipron). Each has its own trial figure, dosing schedule and format, and the figures come from different trials — they are not head-to-head comparisons.
Because efficacy, side-effect tolerance and format preferences differ between people, a prescriber considers your health history and goals rather than assuming one medicine suits everyone. You can see the full range on the treatments overview or the weight-loss injections page, and start a free eligibility check to find out what, if anything, is appropriate for you.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
